WebDisclosure WebDisclosure
Basculer en Français
11206 Companies
248234 Keywords
175981 Articles
134193 Press releases
Headlines Articles Press releases Valkyrie Fund Remove
  1. Home
  2. Companies
  3. Valkyrie Fund
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/11/2024 at 00:05, 2 years 5 months ago

    Valkyrie Fund Announces Portfolio Company Milestones and New Podcast Series

    Valkyrie Fund Chemix Series A Feon Funding Valkyrie Podcast Fund II Launch
  • BRIEF

    published on 05/11/2024 at 00:05, 2 years 5 months ago

    Valkyrie Fund annonce les jalons de la société de portefeuille et une nouvelle série de podcasts

    Fonds Valkyrie Chemix Série A Financement Feon Podcast Valkyrie Lancement Du Fonds II
  • PRESS RELEASE

    published on 05/11/2024 at 00:00, 2 years 5 months ago

    Valkyrie Fund Celebrates Portfolio Successes and Launches Podcast Series

    Valkyrie Fund celebrates milestones achieved by portfolio companies Chemix, Inc. and Feon Energy, Inc. New podcast series launched. Fund II fundraising commences
    Podcast Series Valkyrie Fund Chemix Inc Feon Energy Inc Fund II
    Logo of Valkyrie Fund
Accesswire
  • Published on 10/20/2026 at 23:10, 1 hour 20 minutes ago

    Polaris Renewable Energy Awards Key Supply Contract and Issues Notice to Proceed on Punta Lima Battery Storage Investment

  • Published on 10/20/2026 at 22:00, 2 hours 30 minutes ago

    Eagle Plains Increases Saskatchewan Royalty Portfolio

  • Published on 10/20/2026 at 20:10, 4 hours 20 minutes ago

    Torq Resources Completes Extension of Credit Facility

  • Published on 10/20/2026 at 17:00, 7 hours 30 minutes ago

    GameSquare Announces The "Grand Theft Auto" Effect

  • Published on 10/20/2026 at 14:45, 9 hours 45 minutes ago

    NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials

View all ACCESSWIRE
EQS Group
  • Published on 10/20/2026 at 23:39, 50 minutes ago

    EQS-Adhoc: NEXTDC Limited: M3 Melbourne Power Delay and Revised FY27 Guidance

  • Published on 10/20/2026 at 20:22, 4 hours 8 minutes ago

    Mise à jour de TerraMaster TerraSync : nouveau partage de fichiers et synchronisation à la demande sur Mac

  • Published on 10/20/2026 at 19:32, 4 hours 57 minutes ago

    Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE

  • Published on 10/20/2026 at 19:31, 4 hours 59 minutes ago

    Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE

  • Published on 10/20/2026 at 19:31, 4 hours 59 minutes ago

    Grand City Properties S.A. acquires 20% stake in LEG Immobilien SE to drive strong FFO growth

View all EQS
Les Echos
  • Published on 10/20/2026 at 19:47, 4 hours 43 minutes ago

    Compagnie Chargeurs Invest becomes Belgrano and reaches a new milestone in the implementation of its public share buyback offer (OPRA)

  • Published on 10/20/2026 at 19:47, 4 hours 43 minutes ago

    Compagnie Chargeurs Invest devient Belgrano et franchit une nouvelle étape dans la mise en oeuvre de son OPRA

  • Published on 10/20/2026 at 18:00, 6 hours 30 minutes ago

    ICADE – CP – ACTIVITE AU 30 SEPTEMBRE 2026

  • Published on 10/20/2026 at 18:00, 6 hours 30 minutes ago

    ICADE – PR – 9 MONTH TRADING UPDATE

  • Published on 10/20/2026 at 17:45, 6 hours 45 minutes ago

    PR_Carrefour Sales Q3 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy